Position in RARE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,529,951
-$4,579,911 QoQ
Shares Held
165,617
-65.7% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#81
of 311 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Derivatives in RARE
reported options exposure · as of Dec 31, 2025CallValue
$5,750,000
CallShares
250,000
PutValue
$5,867,300
PutShares
255,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. RARE ranks #35 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in RARE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,529,951 | 165,617 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,109,862 | 482,571 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,867,300 | 255,100 | Put | Sole | 2026-02-18 | |
| 2025-12-31 | $5,750,000 | 250,000 | Call | Sole | 2026-02-18 | |
| 2025-12-31 | $291,433 | 12,671 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,785,408 | 92,600 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $20,474,316 | 563,100 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $10,908,000 | 300,000 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $3,621,000 | 100,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $4,095,351 | 113,100 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $7,857,171 | 216,989 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,530,067 | 178,989 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,943,450 | 179,000 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $6,236,789 | 174,945 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,612,083 | 121,658 | Shares | Sole | 2023-08-14 | |
| 2021-03-31 | $2,095,024 | 18,400 | Put | Sole | 2021-08-18 | |
| 2020-06-30 | $180,922 | 2,313 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $5,749,170 | 73,500 | Call | Sole | 2020-08-14 | |
| 2020-03-31 | $4,443,000 | 100,000 | Call | Sole | 2020-05-15 | |
| 2020-03-31 | $633,216 | 14,252 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||